Deracoxib Impurity 3 | CAS 252561-96-9 - Request Quote
Deracoxib Impurity 3
| SZ CAT No: | SZ-D050023 |
| CAS No | 252561-96-9 |
| Mol.F. | C6H8FN3O2S : HCl |
| Mol.Wt. | 205.2 : 36.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 370874-64-9 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Deracoxib Impurity 3 is chemically 2-Fluoro-4-hydrazinylbenzenesulfonamide hydrochloride. Deracoxib Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Deracoxib Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Deracoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 252561-96-9
Purchase 252561-96-9
Order 252561-96-9
Enquire 252561-96-9
price of 252561-96-9
252561-96-9 Supplier
252561-96-9 Manufacturer
252561-96-9 Exporter
buy high quality Deracoxib Impurity 3
Purchase Deracoxib Impurity 3
Deracoxib Impurity 3 suppliers
Deracoxib Impurity 3 manufacturers
Deracoxib Impurity 3 price
Order Deracoxib Impurity 3
Enquire Deracoxib Impurity 3
Deracoxib Impurity 3 cost
Deracoxib Impurity 3 Supplier
Deracoxib Impurity 3 Distributor
Deracoxib Impurity 3 for Method Validation
Deracoxib Reference Standard
Deracoxib Impurity 3 for ANDA Filing
Deracoxib Impurity 3 for Forced Degradation Studies
Deracoxib Impurity 3 Identification Standards
Deracoxib Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.